Activational role of cannabinoids on movement

European Journal of Pharmacology

Volumn 391, Issue 3, 2000, Pages 269-274

  Sañudo Peña, M Clara ^a   Romero, Julian ^b   Seale, Garrett E ^a   Fernandez Ruiz, J Javier ^b   Walker, J Michael ^a  

^a BROWN UNIVERSITY   (United States)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

9 Tetrahydrocannabinol; Activity; Biphasic effect; Cannabinoid; Movement

Indexed keywords

CANNABINOID; CANNABINOID RECEPTOR AGONIST; DRONABINOL;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; LOCOMOTION; MALE; MOVEMENT (PHYSIOLOGY); NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CANNABINOIDS; CATALEPSY; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MOTOR ACTIVITY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; TETRAHYDROCANNABINOL;

EID: 0343384384     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00044-3     Document Type: Article

References (62)

1. Albin R.L., Young A.B., Penney J.B. The functional anatomy of basal ganglia disorders. Trends Neurosci. 12:1989;366-375.
2. Carlini E.A., Santos M., Claussen U., Bieniek D., Korte F. Structure activity relationship of four tetrahydrocannabinols and the pharmacological activity of five semi-purified extracts of Cannabis sativa. Psychopharmacologia. 18:1970;82-93.
3. 1-cannabinoid receptors in the caudate-putamen. Brain Res. Mol. Brain Res. 67:1999;148-157.
4. Davis W.M., Moreton J.E., King W.T., Pace H.B. Marihuana on locomotor activity: biphasic effect and tolerance development. Res. Commun. Chem. Pathol. Pharmacol. 3:1972;29-35.
5. Deadwyler S.A., Hampson R.E., Bennett B.A., Edwards T.A., Mu J., Pacheco M.A., Ward S.J., Childers S.R. Cannabinoids modulate potassium current in culture hippocampal neurons. Recept. Channels. 1:1993;121-134.
6. Devane W.A., Axelrod J. Enzymatic synthesis of anandamide, an endogenous ligand for the cannabinoid receptor, by brain membranes. Proc. Natl. Acad. Sci. U. S. A. 91:1994;6698-6701.
7. Devane W.A., Hanus L., Breuer A., Pertwee R.G., Stevenson L.A., Griffin G., Gibson D., Mandelbaum A., Etinger A., Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science. 258:1992;1946-1949.
8. Dewey W.L. Cannabinoid pharmacology. Pharmacol. Rev. 38:1986;151-178.
9. Disko U., Haaf A., Heimrich B., Jackisch R. Postnatal development of muscarinic autoreceptors modulating acetylcholine release in the septohippocampal cholinergic system: II. Cell body region: septum. Brain Res. Dev. Brain Res. 108:1998;31-37.
10. Facci L., Dal Toso R., Romanello S., Buriani A., Skaper S.D., Leon A. Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide. Proc. Natl. Acad. Sci. U. S. A. 92:1995;3376-3380.
11. Ferrari F., Ottani A., Giuliani D. Cannabimimetic activity in rats and pigeons of HU 210, a potent antiemetic drug. Pharmacol. Biochem. Behav. 62:1999;75-80.
12. Galiegue S., Mary S., Marchand J., Dussossoy D., Carriere D., Carayon P., Bouaboula M., Shire D., Le Fur G., Casellas P. Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur. J. Biochem. 232:1995;54-61.
13. 9-tetrahydrocannabinol exposure in rats modifies the responsiveness of midbrain dopaminergic neurons in adulthood to a variety of challenges with dopaminergic drugs. Drug Alcohol Depend. 42:1996;155-166.
14. 9-tetrahydrocannabinol. Psychopharmacology. 96:1988;142-144.
15. Herkenham M., Lynn A.B., de Costa B.R., Richfield E.K. Neuronal localization of cannabinoid receptors in the basal ganglia of the rat. Brain Res. 547:1991;267-274.
16. Herkenham M., Lynn A.B., Johnson M.R., Melvin L.S., de Costa B.R., Rice K.C. Characterization and localization of a cannabinoid receptor in rat brain: a quantitative in vitro autoradiographic study. J. Neurosci. 11:1991;563-583.
17. Hollister L.E. Health aspects of cannabis. Pharmacol. Rev. 38:1986;1-20.
18. Howlett A.C. Pharmacology of cannabinoid receptors. Annu. Rev. Pharmacol. Toxicol. 35:1995;607-634.
19. Klemm W.R. Drug effects on active immobility responses: what they tell us about neurotransmitter systems and motor functions. Prog. Neurobiol. 32:1989;403-422.
20. Mackie K., Hille B. Cannabinoid inhibit N-type calcium channels in neuroblastoma-glioma cells. Proc. Natl. Acad. Sci. 89:1992;3825-3829.
21. Mackie K., Lai Y., Westenbroek R., Mitchell R. Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor. Neuroscience. 15:1995;6552-6561.
22. Mailleux P., Vanderhaeghen J.J. Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry. Neuroscience. 48:1992;655-688.
23. Mao A., Freeman K.A., Tallarida R.J. Transient loss of dopamine autoreceptor control in the presence of highly potent dopamine agonists. Life Sci. 59:1996;PL317-PL324.
24. 9-Tetrahydrocannabinol alter cerebral metabolism in a biphasic, dose-dependent manner in rat brain. Eur. J. Pharmacol. 202:1991;373-378.
25. Martin B.R., Welch S.P., Abood M. Progress toward understanding the cannabinoid receptor and its second messenger systems. Adv. Pharmacol. 25:1994;341-397.
26. Matsuda L.A., Lolait S.J., Brownstein M., Young A., Boner T.I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature. 346:1990;561-564.
27. Mechoulam R., Shani A., Edery H., Grundfeld Y. Chemical basis of hashish activity. Science. 169:1970;611-612.
28. Miller A., Sañudo-Peña M.C., Walker J.M. Ipsilateral turning behavior induced by unilateral microinjections of a cannabinoid into the rat subthalamic nucleus. Brain Res. 793:1998;7-11.
29. Miller A., Walker J.M. Effects of a cannabinoid on spontaneous and evoked neuronal activity in the substantia nigra pars reticulata. Eur. J. Pharmacol. 279:1995;179-185.
30. Miller A., Walker J.M. Electrophysiological effects of a cannabinoid on neural activity in the globus pallidus. Eur. J. Pharmacol. 304:1996;29-35.
31. Munro S., Thomas K.L., Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature. 365:1993;61-65.
32. 1 receptor knockout mice. Science. 283:1999;401-404.
33. 1 receptors in mouse urinary bladder. Br. J. Pharmacol. 118:1996;2053-2058.
34. 1 receptors in guinea-pig small intestine. Br. J. Pharmacol. 118:1996;2199-2205.
35. 1 receptors in mouse vas deferens. Eur. J. Pharmacol. 296:1996;169-172.
36. Pertwee R.G., Wickens A.P. Enhancement by chlordiazepoxide of catalepsy induced in rats by intravenous or intrapallidal injections of enantiomeric cannabinoids. Neuropharmacology. 30:1991;237-244.
37. Piomelli D., Beltramo M., Giuffrida A., Stella N. Endogenous cannabinoid signaling. Neurobiol. Dis. 5:1998;462-473.
38. Rinaldi-Carmona M, Barth F, Heaulme M, Shire D, Calandra B, Congy C, Martinez S, Maruani J, Neliat G, Caput D.et al. SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett. 350:1994;240.
39. 2 cannabinoid receptor. J. Pharmacol. Exp. Ther. 284:1998;644-650.
40. 1 receptor ligand. Life Sci. 15:1996;1249-1257.
41. Romero J., de Miguel R., García-Palomero E., Fernández-Ruiz J.J., Ramos J.A. Time-course of the effects of anandamide, the putative endogenous cannabinoid receptor ligand, on extrapyramidal function. Brain Res. 694:1995;223-232.
42. Rosebush P.I., Mazurek M.F. Catatonia after benzodiazepine withdrawal. J. Clin. Psychopharmacol. 16:1995;315-319.
43. 1 cannabinoid receptor antagonist SR 141716A in rats as assessed by electroencephalographic spectral and sleep-waking cycle analysis. Life Sci. 58:1996;PL103-PL110.
44. Sañudo-Peña M.C., Force M., Tsou K., Miller A.S., Walker J.M. Effects of intrastriatal cannabinoids on rotational behavior in rats: interactions with the dopaminergic system. Synapse. 30:1998;221-226.
45. Sañudo-Peña M.C., Patrick S.L., Patrick R.L., Walker J.M. Effects of intranigral cannabinoids on rotational behavior in rats: interactions with the dopaminergic system. Neurosci. Lett. 206:1996;21-24.
46. Sañudo-Peña M.C., Patrick S.L., Patrick R.L., Walker J.M. Cannabinoid control of movement in the basal ganglia in an animal model of Parkinson's disease. Neurosci. Lett. 248:1998;171-174.
47. Sañudo-Peña M.C., Tsou K., Delay E.R., Hohman A.G., Force M., Walker J.M. Endogenous cannabinoids as an aversive or counter-rewarding system in the rat. Neurosci. Lett. 223:1997;125-128.
48. Sañudo-Peña M.C., Tsou K., Walker J.M. Motor actions of cannabinoids in the basal ganglia output nuclei. Life Sci. 65:1999;703-713.
49. Sañudo-Peña M.C., Walker J.M. Role of the subthalamic nucleus on cannabinoid actions in the substantia nigra of the rat. J. Neurophysiol. 77:1997;1635-1638.
50. Sañudo-Peña M.C., Walker J.M. Effects of intrapallidal cannabinoids on rotational behavior in rats: interactions with the dopaminergic system. Synapse. 28:1998;27-32.
51. Sañudo-Peña M.C., Walker J.M. A novel neurotransmitter system involved in the control of motor behavior by the basal ganglia. Ann. N. Y. Acad. Sci. 860:1998;475-479.
52. Sañudo-Peña M.C., Tsou K., Romero J., Mackie K., Walker J.M. Role of the superior collical in the motor effects of cannabinoids and dopamine. Brain Res. 853:2000;207-214.
53. 2: a characterization of expression and adenylate cyclase modulation within the immune system. Toxicol. Appl. Pharmacol. 142:1997;278-287.
54. Schwartz W.J., Smith C.B., Davidsen L., Savaki H., Sokoloff L., Mata M., Fink D.J., Gainer H. Metabolic mapping of functional activity in the hypothalamo-neuro-hypophysial system of the rat. Science. 205:1979;723-725.
55. Shire D., Carillon C., Kaghad M., Calandra B., Rinaldi-Carmona M., LeFur G., Caput D., Ferrara P. An amino-terminal variant of the central cannabinoid receptor resulting from alternative splicing. J. Biol. Chem. 270:1995;3726-3731.
56. 1 cannabinoid receptor knockout mice. Proc. Natl. Acad. Sci. U. S. A. 96:1999;5786-5790.
57. Sukul N.C., Cherian L., Klemm W.R. Alpha noradrenergic agonists promote catalepsy in the mouse. Pharmacol. Biochem. Behav. 31:1988;87-91.
58. Sulcova E., Mechoulam R., Fride E. Biphasic effects of anandamide. Pharmacol. Biochem. Behav. 59:1998;347-352.
59. 1 receptors in the rat central nervous system. Neuroscience. 83:1998;393-411.
60. Tsou K., Nogueron M., Muthian I., Sañudo-Peña M.C., Hillard M.C. Fatty acid amide hydrolase that degrades anandamide is located preferentially in large neurons in the rat central nervous system as revealed by immunohistochemistry. Neurosci. Lett. 254:1998;137-140.
61. Walker, J.M., Huang, S.M., Strangman, N.M., Sañudo-Peña, M.C., 1999. Identification of the role of endogenous cannabinoids in pain modulation: strategies and pitfalls, in press.
62. 1 receptor knockout mice. Proc. Natl. Acad. Sci. U. S. A. 96:1999;5780-5785.